Healthcare provider profile · identity verified

Mark Fogarty, M.D.

Internal Medicine · SAINT LOUIS, MO · NPI 1770577736

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	821	234
Amlodipine Besylate	Amlodipine Besylate	473	132
Losartan Potassium	Losartan Potassium	435	125
Levothyroxine Sodium	Levothyroxine Sodium	308	76
Lisinopril	Lisinopril	297	86
Tamsulosin Hcl	Tamsulosin Hcl	278	70
Metformin Hcl	Metformin Hcl	267	76
Hydrochlorothiazide	Hydrochlorothiazide	264	75
Metoprolol Succinate	Metoprolol Succinate	235	63
Sertraline Hcl	Sertraline Hcl	168	44
Arexvy	Rsvpref3 Antigen/As01e/Pf	165	164
Gabapentin	Gabapentin	162	41
Alendronate Sodium	Alendronate Sodium	154	43
Albuterol Sulfate Hfa	Albuterol Sulfate	152	46
Omeprazole	Omeprazole	151	59
Eliquis	Apixaban	128	33
Simvastatin	Simvastatin	124	35
Escitalopram Oxalate	Escitalopram Oxalate	110	27
Metoprolol Tartrate	Metoprolol Tartrate	105	28
Rosuvastatin Calcium	Rosuvastatin Calcium	101	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	95	28
Pantoprazole Sodium	Pantoprazole Sodium	95	29
Finasteride	Finasteride	93	24
Furosemide	Furosemide	92	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	91	22
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	87	23
Allopurinol	Allopurinol	79	21
Spironolactone	Spironolactone	79	19
Potassium Chloride	Potassium Chloride	72	17
Carvedilol	Carvedilol	71	19
Fluticasone Propionate	Fluticasone Propionate	63	16
Meloxicam	Meloxicam	63	13
Ozempic	Semaglutide	61	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	55	14
Pravastatin Sodium	Pravastatin Sodium	54	17
Mirtazapine	Mirtazapine	51	13
Clopidogrel	Clopidogrel Bisulfate	50	15
Trazodone Hcl	Trazodone Hcl	50	13
Ezetimibe	Ezetimibe	48	13
Tramadol Hcl	Tramadol Hcl	47	21
Atenolol	Atenolol	46	13
Pregabalin	Pregabalin	46	suppressed
Citalopram Hbr	Citalopram Hydrobromide	43	15
Buspirone Hcl	Buspirone Hcl	42	22
Glimepiride	Glimepiride	42	13
Fluoxetine Hcl	Fluoxetine Hcl	40	12
Warfarin Sodium	Warfarin Sodium	40	suppressed
Famotidine	Famotidine	39	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	12
Xarelto	Rivaroxaban	37	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	35	suppressed
Farxiga	Dapagliflozin Propanediol	34	suppressed
Ipratropium Bromide	Ipratropium Bromide	34	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	18
Valsartan	Valsartan	32	suppressed
Lovastatin	Lovastatin	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	30	suppressed
Torsemide	Torsemide	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	11
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Arnuity Ellipta	Fluticasone Furoate	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Prednisone	Prednisone	24	16
Alprazolam	Alprazolam	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Lactulose	Lactulose	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Irbesartan	Irbesartan	20	suppressed
Lorazepam	Lorazepam	20	11
Valacyclovir	Valacyclovir Hcl	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Duloxetine Hcl	Duloxetine Hcl	18	suppressed
Glipizide	Glipizide	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Primidone	Primidone	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	13
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Jardiance	Empagliflozin	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Felodipine Er	Felodipine	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Nystatin	Nystatin	14	suppressed
Tiadylt Er	Diltiazem Hcl	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Estradiol	Estradiol	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Tiotropium Bromide	Tiotropium Bromide	13	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Cephalexin	Cephalexin	12	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Clonazepam	Clonazepam	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Mirabegron Er	Mirabegron	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Nystop	Nystatin	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Prolia	Denosumab	11	suppressed
Ramipril	Ramipril	11	suppressed
Topiramate	Topiramate	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error